Aptevo Therapeutics (APVO) Inventory Average (2016 - 2019)
Aptevo Therapeutics (APVO) has disclosed Inventory Average for 4 consecutive years, with $6.8 million as the latest value for Q4 2019.
- Quarterly Inventory Average rose 136.72% to $6.8 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2019, up 136.72% year-over-year, with the annual reading at $4.0 million for FY2019, 66.65% up from the prior year.
- Inventory Average hit $6.8 million in Q4 2019 for Aptevo Therapeutics, down from $7.2 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $15.9 million in Q3 2016 to a low of $1.1 million in Q4 2017.
- Historically, Inventory Average has averaged $5.2 million across 4 years, with a median of $4.4 million in 2017.
- Biggest five-year swings in Inventory Average: plummeted 81.18% in 2017 and later skyrocketed 165.88% in 2019.
- Year by year, Inventory Average stood at $6.0 million in 2016, then tumbled by 81.18% to $1.1 million in 2017, then surged by 154.04% to $2.9 million in 2018, then soared by 136.72% to $6.8 million in 2019.
- Business Quant data shows Inventory Average for APVO at $6.8 million in Q4 2019, $7.2 million in Q3 2019, and $5.7 million in Q2 2019.